IP Library Granted Patent US 12,409,135
Granted Patent B2
US 12,409,135 · App. 18/062,416 · Granted Sep 9, 2025

Neoepitope vaccine delivery vehicle and methods of making the same

Inventors: Philip T. Liu (Culver City, CA); Clifford Anders Olson (Culver City, CA); Wade Nichols Richardson (Culver City, CA); Wendy Higashide (Culver City, CA)
Assignee: ImmunityBio, Inc.
A61K9/06A61K38/063A61K41/0028A61K47/36C12N15/1055C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,409,135
App. No.
18/062,416
Granted
Sep 9, 2025
Kind
B2
Abstract

Disclosed herein are mannan nanogels as a novel vaccine delivery platform as well as a novel method of making a self-assembling mannan nanogel for in vivo delivery of therapeutic agents.

Claims (14)

1. A method of making a self-assembling mannan nanogel for in vivo delivery of therapeutic agents, the method comprising:

a. oxidizing mannan with periodate (NaIO4);

b. purifying the oxidized mannan;

c. adding aniline to the purified oxidized mannan to produce a mannan derivative with hydrophobic phenylimine groups covalently attached to the mannan, wherein the mannan derivative self-assembles into a mannan nanogel;

d. further reacting the mannan nanogel with succinate dihydrazide (SDH) and 3,3′-Dithiobis(propanoic dihydrazide) (DPDH), thereby introducing dihydrazide crosslinkers into the self-assembled mannan nanogel;

e. further reducing the mannan nanogel disulfide crosslinks with (tris(2-carboxyethyl) phosphine) (TCEP);

f. reducing imines and residual aldehydes in the mannan nanogel with borohydride (NaBH4); and

g. activating thiols in the mannan nanogel with 2,2-dithiopyridine (DTP), thereby preparing the mannan nanogel for loading with thiol-containing cargo.

2. The method of claim 1 , wherein the thiol-containing cargo is loaded onto the DTP-activated nanogel, wherein the cargo is comprised of one or more peptides.

3. The method of claim 1 , wherein dihydrazide crosslinked nanogels are coated with NaIO4-oxidized mannan.

4. The method of claim 1 , wherein the thiol-containing cargo is loaded into the DTP-activated nanogel, wherein the cargo is comprised of one or more peptides, and optionally glutathione (GSH).

5. The method of claim 1 , wherein the thiol-containing cargo is loaded into the DTP-activated nanogel, wherein the cargo is comprised of one or more viral antigens.

6. The method of claim 1 , wherein the thiol-containing cargo is loaded into the DTP-activated nanogel, wherein the cargo is comprised of one or more nucleic acids.

7. The method of claim 6 , wherein the nucleic acids are comprised of thiolated mRNA.

Assignments (2)
SECURITY INTEREST Recorded Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC; ALTOR BIOSCIENCE, LLC; ETUBICS CORPORATION; IGDRASOL, INC.
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2022
From: LIU, PHILIP T.; OLSON, CLIFFORD ANDERS; RICHARDSON, WADE NICHOLS; HIGASHIDE, WENDY
To: IMMUNITYBIO, INC.
Reel/Frame 062224/0300 →
Continuity (2)
Provisional Application 63287176 · Dec 8, 2021
Related Publication 20230172852A1 · Jun 8, 2023
References Cited (65)
US 5853737A · Modlin et al. · 1998 [cited by applicant]
US 6238676B1 · Porcelli et al. · 2001 [cited by applicant]
US 8759322B2 · Akiyoshi et al. · 2014 [cited by applicant]
US 8961983B2 · Akiyoshi et al. · 2015 [cited by applicant]
US 8987230B2 · Akiyoshi et al. · 2015 [cited by applicant]
US 9205103B2 · Portela Da Gama et al. · 2015 [cited by applicant]
US 10391060B2 · Pilgaonkar et al. · 2019 [cited by applicant]
US 20120029175A1 · Nagura et al. · 2012 [cited by applicant]
US 20130045242A1 · Portela Da Gama · 2013 [cited by examiner]
US 20150231268A1 · Nakai et al. · 2015 [cited by applicant]
US 20170202789A1 · Sexton et al. · 2017 [cited by applicant]
US 20190111078A1 · Shiku et al. · 2019 [cited by applicant]
US 20190142960A1 · Haimovitz-Friedman et al. · 2019 [cited by applicant]
US 20190351043A1 · Briles et al. · 2019 [cited by applicant]
US 20210299061A1 · Malkoch et al. · 2021 [cited by applicant]
US 20210322531A1 · Hayashi et al. · 2021 [cited by applicant]
US 20220111061A1 · Harada · 2022 [cited by examiner]
CN 110156911 · 2019 [cited by applicant]
FR 2839517 · 2003 [cited by applicant]
FR 3104951 · 2021 [cited by applicant]
JP 2007252304 · 2007 [cited by applicant]
JP 4550555B · 2010 [cited by applicant]
JP 4599550B · 2010 [cited by applicant]
JP 2012232949 · 2012 [cited by applicant]
JP 5866724 · 2016 [cited by applicant]
WO WO9809650 · 1998 [cited by applicant]
WO WO00020563 · 2000 [cited by applicant]
WO WO00059948 · 2000 [cited by applicant]
WO WO02076441 · 2002 [cited by applicant]
WO WO2007119859 · 2007 [cited by applicant]
WO WO2013160190 · 2013 [cited by applicant]
WO WO2014054588 · 2014 [cited by applicant]
WO WO2014157606 · 2014 [cited by applicant]
WO WO2015119181 · 2015 [cited by applicant]
WO WO2017170494 · 2017 [cited by applicant]
WO WO2020027309 · 2020 [cited by applicant]
WO WO2020045488 · 2020 [cited by applicant]
WO WO2020203731 · 2020 [cited by applicant]
Ojala et al., Published Jun. 2, 2000, Carbohydrate Research, vol. 326, Issue 2, pp. 104-112 (Year: 2000). [cited by examiner]
Xu et al., Published Oct. 30, 2018, ACS Applied Materials & Interfaces, vol. 10, Issue 46, pp. 39494-39504 (Year: 2018). [cited by examiner]
Wagh et al., Published Jan. 1, 2013, Methods for Conjugating Antibodies to Nanocarriers, in Ducry, L. Antibody-Drug Conjugates, (New York, Humana Press, 2013), pp. 249-266 (Year: 2013). [cited by examiner]
Felber, M., Published Jan. 7, 2016, Ph.D. Dissertation, Universität Zürich, pp. 1-160, DOI: 10.5167/uzh-118686 (Year: 2016). [cited by examiner]
Akiyama et al., Self-assembled nanogels of cholesteryl-modified polysaccharides: effect of the polysaccharide structure on their association characteristics in the dilute and semidilute regimes, Biomacromolecules, Jul. … [cited by applicant]
Ferreira et al., “Development of Multifunctional Mannan Nanogel,” ProQuest LLC, ProQuest No. 10592490, Universidade do Minho, Thesis for PhD Degree in Biomedical Engineering, Apr. 2012, 4 pages, abstract only. [cited by applicant]
Ferreira et al., “Self-Assembled Mannan Nanogel: Cytocompatibility and Cell Localization,” Journal of Biomedical Nanotechnology, 2012, vol. 8(3), pp. 1-9. [cited by applicant]
Ferreira et al., “Self-Assembled Nanogel Made of Mannan: Synthesis and Characterization,” Langmuir, Jun. 2, 2010, 26(13), pp. 11413-11420. [cited by applicant]
Ferreira et al., “Supramolecular assembled nanogel made of mannan,” Journal of Colloid and Interface Science, Sep. 1, 2011, vol. 361(1), pp. 97-108. [cited by applicant]
Ferreirs et al., “Polymeric nanogels as vaccine delivery systems,” Nanomedicine: Nanotechnology, Biology and Medicine, Feb. 2013, vol. 9(2), pp. 159-173. [cited by applicant]
Grego et al., “Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles,” Current Topics in Microbiology and Immunology, Author Manuscript, 2021, vol. 433, pp. 29-76, 45 pages. [cited by applicant]
Gu, “A Novel Hydrophobized Polysaccharide/Oncoprotein Complex Vaccine Induces in Vitro and In Vivo Cellular and Humoral Immune Responses Against HER2-expressing Murine Sarcomas,” Cancer Research, 1998, vol. 58(15), pp. … [cited by applicant]
Ikuta et al., “Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a… [cited by applicant]
Kang, “Specific Partition of Surface-Modified Liposomes in Aqueous PEO/Polysaccharide Two-Phase Systems,” Adsorption and Aggregation of Surfactants in Solution, 1st Edition, 2003, vol. 109, pp. 520-542. [cited by applicant]
Lang et al., “Carbohydrate Conjugates in Vaccine Developments,” Frontiers in Chemistry, Apr. 15, 2020, vol. 8(284), 1-25 pages. [cited by applicant]
Leber et al., “α-Mannosyl-Functionalized Cationic Nanohydrogel Particles for Targeted Gene Knockdown in Immunosuppressive Macrophages,” Macromolecular Bioscience, Jul. 2019, vol. 19(7), e1900162, 12 pages. [cited by applicant]
Malik et al., “Efaverinz and nano-gold-loaded mannosylated niosomes: a host cell-targeted topical HIV-1 prophylaxis via thermogel system,” Artificial Cells, Nanomedicine, and Biotechnology, 2018, vol. 46(S1), pp. S79-S9… [cited by applicant]
Miki et al., “Methylation-triggered fractionation of lignocellulosic biomass to afford cellulose-, hemicellulose-, and lignin-based functional polymers via click chemistry,” Green Chemistry, Apr. 22, 2020, vol. 22, pp. … [cited by applicant]
Mutalabisin et al., “pH Responsive Polymers in Drug Delivery,” Research Journal of Pharmacy and Technology, Nov. 2018, vol. 11(11), pp. 5115-5122. [cited by applicant]
Patel et al., “Recent Trends in Microbially and/or Enzymatically Driven Colon-Specific Drug Delivery Systems,” Critical Reviews™M in Therapeutic Drug Carrier Systems, 2011, vol. 28(6), pp. 489-552. [cited by applicant]
Rodriguez et al., “The Surfaces of the [cited by applicant]
Shiku et al., “A Novel Hydrophobized Polysaccharide/Oncoprotein Complex Vaccine for HER2 Gene Expressing Cancer,” Biomedical Polymers and Polymer Therapeutics, 2002, pp. 331-337. [cited by applicant]
Varshosaz et al., “Supramolecular Self-Assembled Nanogels a New Platform for Anticancer Drug Delivery,” Current Pharmaceutical Design, 2017, vol. 23(35), pp. 5242-5260. [cited by applicant]
Vigerust et al., “Stable Expression and Characterization of an Optimized Mannose Receptor,” Journal of Clinical & Cellular Immunology, 2015, vol. 6(3), 10 pages. [cited by applicant]
Yamane et al., “Hybrid Nanoapatite by Polysaccharide Nanogel-templated Mineralization,” Journal of Bioactive and Compatible Polymers, Mar. 1, 2009, vol. 24(2), pp. 151-168. [cited by applicant]
Zhang et al., “Cholesteryl-Modification of a Glucomannan from Bletilla striata and Its Hydrogel Properties,” Molecules, 2014, vol. 19, pp. 9089-9100. [cited by applicant]
International Search Report and Written Opinion for International (PCT) Application No. PCT/US2022/081025, dated Apr. 17, 2023 11 pages. [cited by applicant]